iPhone Competition
advanced search

Welcome: Guest

log in

Cytori Therapeutics Inc

Premium Company Profile

Publication Date April 2008
Publisher Datamonitor
Product Type Report
Pages 45
ISBN Number not applicable
Product Code DAT11498
Price

£265.00
approximately: $521 | €337

PDF Buy Now
PRINT £315 ($619 | €400) Buy Now
Order above formats by FAX Order by FAX

Summary

Introduction

Cytori Therapeutics (previously MacroPore Biosurgery), based in San Diego, California, is one of the leading companies in the development and commercialization of regenerative medicine products.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

The company has two operating segments: regenerative cell technology, which is developing and commercializing stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery; and MacroPore Biosurgery, which develops and manufactures bioresorbable, surgical implants. The company's total revenues, which consisted of product revenues and development revenues, declined from $9 million to $8 million during 2002-2006, mainly due to the company's divestiture of product lines including majority of its thin film product business. Cytori Therapeutics is forecast to record a significant growth in its revenues between 2006 and 2010, as its total revenues are expected to reach $59.1 million by 2010 from $7.9 million in 2006. The increase in revenues will be attributable to the increased acceptance of the company's products in the coming years.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

  • Overview
  • Catalyst
  • Summary
    • Company Structure
    • Company Overview and Key Facts
    • Business Description
    • History
    • Locations and Subsidiaries
    • Company Financials
    • Stock Market Performance
    • P&l
    • Balance Sheet
    • Cash Flow
    • Business Segment Performance
    • Products & Services
    • Marketed Products
    • Pipeline Products
    • Historical Product Sales
    • Ac Forecast Product Sales
    • Competitors and Strategic Business Relationships
    • Key Competitors
    • Key Suppliers
    • Key Clients
    • Shareholding Structure
    • Strategy
    • Corporate Strategy
    • SWOT Analysis
    • Overview
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
    • Value Chain Analysis
    • Overview
    • Product Development
    • Manufacturing
    • Sales
    • Key Employees
    • List of Key Employees
    • Key Employee Biographies
    • Financial and Operational Overview
    • Financial and Operational Overview
  • Appendix
    • Ask The Analyst
    • Datamonitor Consulting
    • Disclaimer
  • Table of Figures
    • Figure 1: Cytori Therapeutics- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Figure 2: Cytori Therapeutics- Key Strategic Revenues, 2002-2006 ($ Mn)
    • Figure 3: Cytori Therapeutics- Key Strategic Products Revenues, 2006-2010 ($ Mn)
  • Table of Tables
    • Table 1: Cytori Therapeutics- Key Facts
    • Table 2: Cytori Therapeutics- Locations and Subsidiaries
    • Table 3: Cytori Therapeutics- Year-End Share Price and Market Capitalization, 2002-2006 ($)
    • Table 4: Cytori Therapeutics- Key Events Impacting Share Price Performance
    • Table 5: Cytori Therapeutics- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Table 6: Cytori Therapeutics- Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
    • Table 7: Cytori Therapeutics- Balance Sheet, 2002-2006 ($ Mn)
    • Table 8: Cytori Therapeutics- Cash Flow, 2002-2006 ($ Mn)
    • Table 9: Cytori Therapeutics- Revenue Breakdown by Division, 2002-2006 ($ Mn)
    • Table 10: Cytori Therapeutics- Marketed Products
    • Table 11: Cytori Therapeutics- in-House Pipeline Products
    • Table 12: Cytori Therapeutics- Key Strategic Revenues, 2002-2006 ($ Mn)
    • Table 13: Cytori Therapeutics- Key Strategic Revenues, 2006-2010 ($ Mn)
    • Table 14: Cytori Therapeutics- Key Competitors
    • Table 15: Cytori Therapeutics- Key Suppliers
    • Table 16: Cytori Therapeutics- Key Clients
    • Table 17: Cytori Therapeutics - Key Shareholders
    • Table 18: Cytori Therapeutics- SWOT Analysis Summary
    • Table 19: Cytori Therapeutics- Value Chain Analysis
    • Table 20: Cytori Therapeutics- Key Employees
    • Table 21: Cytori Therapeutics - Financial and Operational Overview